Paul A. Hamlin, MD -- Clinical Director, Lymphoma Outpatient Unit

Paul A. Hamlin, MD

Medical Oncologist


Medical Director, David H. Koch Center for Cancer Care

Clinical Expertise

Diffuse Large B Cell Lymphoma in the Elderly; Antibody Drug Conjugates; non-Hodgkin Lymphoma; Hodgkin's Disease; Mantle Cell Lymphoma

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Hamlin accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, SUNY Health Science Center at Brooklyn


Internal Medicine - New York University Medical Center


Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

I am a board-certified medical oncologist and a member of the MSK Lymphoma Service. My colleagues and I work to ensure a world-class collaborative environment, bringing the medical expertise, access to cutting-edge clinical research, and specialized cancer care to our patients.

I have specialized in the care of patients with Hodgkin’s disease and non-Hodgkin lymphoma (NHL) for more than a decade as an integral member of the Lymphoma Service in the Division of Hematologic Oncology. I have served as the Director of our outpatient lymphoma clinics at MSK’s main location in Manhattan and continue to lead our innovation efforts at our 64th Street location.

My clinical research interests have focused on developing novel therapies and dedicated treatment programs for older patients with lymphoma, addressing the complex interplay between aging and a cancer diagnosis. As part of a multidisciplinary MSK team that cares for patients age 65 and older, I have worked to develop new treatment strategies for older patients with diffuse large B-cell, mantle cell, and Hodgkin lymphoma. Ongoing research efforts are developing new screening tools to identify patients at increased risk for treatment side effects and clinical trials specifically aimed at addressing the needs of the older patient population. We have as our shared goal the development of effective risk-adapted therapies to minimize the side effects of treatments while maximizing their effectiveness.

As a clinical researcher, I have been the principle investigator (PI) or co-PI of more than 30 clinical trials. My work continues to explore novel biologic and immunotherapeutic agents for the treatment of both NHL and Hodgkins, with phase I and II trials focused on new antibody combinations, antibody drug conjugates, immunotoxins, and small molecule inhibitors. 


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Hamlin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.